This expert seminar was intended to help shape the research agenda around the implications of national drug policy reform for the UN drug control conventions and international law more broadly and orient the discussion at the 2016 UNGASS.
In the lead up to the negotiations of the UNGASS outcome document, IDPC has drafted this advocacy note with recommendations on the structure and contents of the “zero draft”.
This EMCDDA paper considers the rehabilitative measures of treating, educating or reintegrating drug users as alternatives or additions to conviction or punishment that are established in the laws of many countries in Europe today.
The latest survey on coca in Peru, produced by UNODC in collaboration with the Peruvian government, shows that the area of cultivation and cocaine production of the country fell by 13.9 percent from the year 2013 to 2014.
This NDARC study concludes that harm reduction strategies and health promotion messages need to target risky behaviours to educate and inform people who inject drugs.
This informative factsheet was drafted by the African Palliative Care Association and the Palliative Care Association of Uganda to provide information on palliative care.
To contribute to the UNGASS debates, the Graduate Institute of International and Development Studies held a public policy dialogue to help the technical, professional and diplomatic communities in Geneva to explore options for policy makers.
The training module was developed as a result of the workshop which was organised for CAHR partners in December 2014. This three days training module can be used to build capacity of service providers aiming to improve access to care and treatment for HIV positive people using drugs.
Since Washington’s passage of I-502, retail marijuana sales have generated over $80 million in tax revenues and the state has saved millions of dollars by no longer arresting and prosecuting low-level marijuana offences.
In this study published in the British Journal of Psychiatry, supervised injectable heroin was found to be an effective way of treating heroin dependence refractory to standard treatment, in particular for patient populations previously considered unresponsive to treatment.
